Travaux scientifiques
Doç. Dr. Aysun Şentürk Yıkılmaz
94 publications. La source de l’information est indiquée à côté de chaque publication.
-
EFFECT OF THE INITIAL TREATMENT ON THE MUSCLE MASS AND RESPONSE TO THERAPY IN HODGKIN’S LYMPHOMA
AYBU AVESIS, 2018
Source : OpenAlex
-
The Place of Interventional Hematologic Investigations in Unknown Fever Etiology
Ankara Medical Journal, 2017
DOI 10.17098/amj.370672 Texte intégral en libre accèsSource : OpenAlex
-
Stimulated thyroglobulin values above 5.6 ng/ml before radioactive iodine ablation treatment following levothyroxine withdrawal is associated with a 2.38-fold risk of relapse in Tg-ab negative subjects with differentiated thyroid cancer.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2017
DOI 10.1007/s12094-017-1640-3 PMID 28258491 5 citations (Europe PMC) Source : ORCID
-
DOES EARLY RESPONSE TO FIRST LINE CORTICOSTEROID THERAPY PREDICT REQUIREMENT FOR SECOND LINE THERAPY IN IMMUNE THROMBOCYTOPENIA
Haematologica, 2017
Source : ORCID
-
TERAPÖTİK PLAZMAFEREZ, TROMBOTİK TROMBOSİTOPENİK PURPURA TEDAVİSİNDE ETKİLİ MİDİR?
AYBU AVESIS, 2017
Source : OpenAlex
-
DOES FERRITIN AND VITAMIN B12 LEVELS HAVE PROGNOSTIC HAVE PROGNOSTIC SIGNIFICANCE IN MULTIPLE MYELOMA PATIENTS?
AYBU AVESIS, 2017
Source : OpenAlex
-
HEMATOLOJİ KONSÜLTASYONLARI: TEK MERKEZ
AYBU AVESIS, 2017
Source : OpenAlex
-
POLİSİTEMİ VERA OLGULARININ KARAKTERİSTİKLERİ, TEK MERKEZ DENENYİMİ
AYBU AVESIS, 2017
Source : OpenAlex
-
ESANSİYEL TROMBOSİTOZ OLGULARININ TEK MERKEZDEN DEMOGRAFİK VERİLERİ
AYBU AVESIS, 2017
Source : OpenAlex
-
DOES FERRITIN AND VITAMIN B12 LEVELS HAVE PROGNOSTIC SIGNIFICANCE IN MULTIPLE MYELOMA PATIENTS?
AYBU AVESIS, 2017
Source : OpenAlex
-
ÇOK NADİR BİR DURUM OLARAK SOĞUK AGLÜTİNİN HASTALIĞI İLE GELEN SİSTEMİK LUPUS ERİTEMATOZİS OLGUSU
AYBU AVESIS, 2017
Source : OpenAlex
-
MULTIPLE MYELOMA IN PATIENTS OLDER THAN 65 YEARS: A COMPARATIVE STUDY WITH YOUNGER ADULT MULTILE MYELOMA PATIENTS
AYBU AVESIS, 2017
Source : OpenAlex
-
POLİSTEMİA VERA OLGULARININ KARAKTERİSTİKLERİ, TEK MERKEZ DENEYİMİ
AYBU AVESIS, 2017
Source : OpenAlex
-
Multiple myeloma in patients older than 65 years: A comparative study with younger adult multiple myeloma patients
AYBU AVESIS, 2017
Source : OpenAlex
-
TROMBOTİK TROMBOSİTOPENİK PURPURA OLGULARIMIZIN TERAPÖTİK PLAZMAFEREZ SONUÇLARI
AYBU AVESIS, 2017
Source : OpenAlex
-
ERKEN EVRE KLL HASTALARININ 25 HİDROKSİ D VİTAMİNİ DÜZEYLERİ SAĞLIKLI POPULASYONDAN DÜŞÜKTÜR
AYBU AVESIS, 2017
Source : OpenAlex
-
REANİMASYON YOĞUN BAKIM OLGULARINDA TERAPÖTİK PLAZMAFERZ: TEK MERKEZ DENEYİMİ
AYBU AVESIS, 2017
Source : OpenAlex
-
ÇOK NADİR BİR DURUM OLARAK SOĞUK AGLÜTİNİN HASTALIĞI İLE GELEN SİSEMİK LUPU ERİTEMATOSİS OLGUSU
AYBU AVESIS, 2017
Source : OpenAlex
-
Epidemiology of Vitamin B12 Deficiency
InTech eBooks, 2016
DOI 10.5772/63760 8 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
TWO CASES OF ACQUIRED HEMOPHILIA A
Thrombosis Research, 2016
Source : ORCID
-
MANAGEMENT OF PATIENTS WITH ACUTE LEUKEMIA WHO HAD ALLOIMMUNE THROMBOCYTOPENIA UNTIL RECOVERY PERIOD
AYBU AVESIS, 2016
Source : OpenAlex
-
THE CRYOPRECIPITATE REPLACEMENT FOR THE ACUTE PROMYELOCYTIC LEUKEMIA CASES WHOPRESENTED WITH HYPOFIBRINOGENEMIA
AYBU AVESIS, 2016
Source : OpenAlex
-
The distrubution of component use according to clinics single center experience
AYBU AVESIS, 2016
Source : OpenAlex
-
Hodgkin lenfomada PD-1, PD-L1 eksresyonunun EBV (Ebstein Barr Virus) ile ilişkisi ve prognostik önemi
AYBU AVESIS, 2016
Source : OpenAlex
-
THE DISTRUBUTION OF COMPONENT USE ACCORDİNG TO CLINICS SINGLE CENTER EXPERIENCE
AYBU AVESIS, 2016
Source : OpenAlex
-
THREE YEAR EXPERIENCE TRANSITION FROM REGIONAL BLOOD CENTER TO TRANSFUSION CENTER
AYBU AVESIS, 2016
Source : OpenAlex
-
THE CRYOPRECIPITATE REPLACEMENT FOR THE ACUTE PROMYELOCYTIC LEUKEMIA CASES WHO PRESENTED WITH HYPOFIBRINOJENEMIA
AYBU AVESIS, 2016
Source : OpenAlex
-
THE DISTRUBUTION OF COMPONET USE ACCORDING TO CLINICS SINGLE CENTER EXPERIENCE
AYBU AVESIS, 2016
Source : OpenAlex
-
HODGKİN LENFOMADA PD-1, PD-L1EKSPRESYONUNUN EBV(EPSTEİN-BARR VİRUS)İLE İLİŞKİSİ VE PROGNOSTİK ÖNEMİ
AYBU AVESIS, 2016
Source : OpenAlex
-
LEAST INCOMPATIBLE RED BLOOD CELL UNIT USING HOW SAFETY DECISION
AYBU AVESIS, 2016
Source : OpenAlex
-
The predictive value of epidemiological characteristics, clinical and laboratory findings in adult lymphadenopathy etiology.
PubMed, 2015
PMID 26367715 6 citations (OpenAlex) Source : OpenAlex
-
EDTA-Dependent Pseudothrombocytopenıa in an Elderly Patient with Rheumatoid Arthritis: A Case Report
Gazi Medical Journal, 2015
DOI 10.12996/gmj.2015.62 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
The predictive value of epidemiological characteristics, clinical and laboratory findings in adult lymphadenopathy etiology
European Review for Medical and Pharmacological Sciences, 2015
Source : ORCID
-
Cerebral venous sinus thrombosis in acute promyelocyticleukemia APL a possible association to ATRA
AYBU AVESIS, 2015
Source : OpenAlex
-
INTENSE MANAGEMENT OF ELDERLY ACUTE MYELOID LEUKEMIA YES
AYBU AVESIS, 2015
Source : OpenAlex
-
Diffuse large B cell lymphoma and plasma cell myeloma developing years after theraphy for hodgkin lymphoma
AYBU AVESIS, 2015
Source : OpenAlex
-
Bluriness differential diagnosis don t forget acute promyelocytic leukemia
AYBU AVESIS, 2015
Source : OpenAlex
-
Peripheral T cell lymphomas analysis of 11 cases from a single center
AYBU AVESIS, 2015
Source : OpenAlex
-
WHAT SHOUL BE THE RIGHT TIME FOR THE CHELATION THERAPY IN MYELODYSPLASTIC SYNDROME
AYBU AVESIS, 2015
Source : OpenAlex
-
WE WOULD NOT OVERLOOK ENDOCRINE DISORDERS IN ANEMIA
AYBU AVESIS, 2015
Source : OpenAlex
-
AN IMPORTANT PROGNOSTIC FACTOR IN ACUTE LEUKEMIA INFECTION
AYBU AVESIS, 2015
Source : OpenAlex
-
Unexpected adverse effect of cloforabin bronze hyperpigmentation
AYBU AVESIS, 2015
Source : OpenAlex
-
BLURRINESS DIFFERANTIAL DIAGNOSIS DON T FORGET ACUTE PROMYELOCYTIC LEUKEMIA
AYBU AVESIS, 2015
Source : OpenAlex
-
Stimulated serum Tg ≥0.285 ng/ml in anti-Tg(−) cases had 3.087 times increased likelihood of recurrence of differentiated thyroid cancer: a single center experience
Endocrine Abstracts, 2013
DOI 10.1530/endoabs.32.p1104 Source : OpenAlex